Sofinnova Capital IX raises 333 mln euros
Sofinnova Partners said Oct. 17 that its latest early-stage healthcare venture capital fund closed on 333 million euros ($370.3 million). Sofinnova Capital IX will invest in the healthcare industry and more specifically in the biopharmaceutical and medical device sectors.
17 October 2019•3 mins read
